Skip to content

Telix Pharmaceuticals Ltd

TLX· NasdaqCore metricsCIK 2007191

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -3.70%
Market cap
—
no share count on file
Filings
109
$803.79M
FY 2025+55.6% FY25 yoy
-$7.13M
FY 2025N/M FY25 yoy
$29.78M
FY 2025−46.0% FY25 yoy
-$42.99M
FY 2025derivedN/M FY25 yoy
-$0.02
FY 2025N/M FY25 yoy
$141.87M
FY 2025−67.8% FY25 yoy

Price

$9.378.41%$0.86past year
Nov 12, 2026 · IEX last sale
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$803.79MFY 2025
$803.79M0FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$803,794,000reported
FY 20242024-12-31$516,551,000reported
FY 20232023-12-31$332,978,000reported

Pharmaceutical preparations

Telix Pharmaceuticals Ltd is the 40th largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Telix Pharmaceuticals Ltd · CIK 2007191 · Engraved from SEC EDGAR